| Dr Muhammad Kashlan, MD | |
|
75 Barclay Cir Ste 205, Rochester Hills, MI 48307-5821 | |
| (248) 651-6430 | |
| (248) 650-1382 |
| Full Name | Dr Muhammad Kashlan |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 35 Years |
| Location | 75 Barclay Cir Ste 205, Rochester Hills, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346224078 | NPI | - | NPPES |
| 4149097 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 4301064902 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beaumont Hospital, Troy | Troy, MI | Hospital |
| Ascension Providence - Crittenton Hospital Medical Center | Rochester, MI | Hospital |
| Mclaren Lapeer Region | Lapeer, MI | Hospital |
| Mclaren Oakland | Pontiac, MI | Hospital |
| Mclaren Greater Lansing | Lansing, MI | Hospital |
| Entity Name | Mclaren Oakland |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053463778 PECOS PAC ID: 0547173213 Enrollment ID: O20031111000770 |
News Archive
Expression of a toxic RNA that leads to Fragile X Tremor Ataxia Syndrome is modifiable by genetic or pharmacologic means, according to new research from U-M Medical School scientists.
In 2009, the Hypertension and Preeclampsia Intervention Trial At near Term-I (HYPITAT- I) trial showed that inducing labor in women with gestational hypertension or preeclampsia at the end of pregnancy reduces the number of high risk situations for the mother, without compromising the health of newborns.
QLT Inc. ("QLT" or the "Company") is pleased to announce the establishment of its commercial presence in the United States through a newly formed U.S. subsidiary, QLT Ophthalmics, Inc. ("QOI"). QOI will take on the sales and marketing of Visudyne(R) in the U.S.
Safe levels of electrical stimulation can enhance your capacity to think more creatively, according to a new study by Georgetown researchers.
The U.S. Food and Drug Administration today approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated with resistance to the individual components of Dovato.
› Verified 4 days ago
| Entity Name | Mclaren Central Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245266063 PECOS PAC ID: 6103733092 Enrollment ID: O20040309000447 |
News Archive
Expression of a toxic RNA that leads to Fragile X Tremor Ataxia Syndrome is modifiable by genetic or pharmacologic means, according to new research from U-M Medical School scientists.
In 2009, the Hypertension and Preeclampsia Intervention Trial At near Term-I (HYPITAT- I) trial showed that inducing labor in women with gestational hypertension or preeclampsia at the end of pregnancy reduces the number of high risk situations for the mother, without compromising the health of newborns.
QLT Inc. ("QLT" or the "Company") is pleased to announce the establishment of its commercial presence in the United States through a newly formed U.S. subsidiary, QLT Ophthalmics, Inc. ("QOI"). QOI will take on the sales and marketing of Visudyne(R) in the U.S.
Safe levels of electrical stimulation can enhance your capacity to think more creatively, according to a new study by Georgetown researchers.
The U.S. Food and Drug Administration today approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated with resistance to the individual components of Dovato.
› Verified 4 days ago
| Entity Name | Pulmonary Critical Care And Sleep Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043311616 PECOS PAC ID: 3678679107 Enrollment ID: O20070430000567 |
News Archive
Expression of a toxic RNA that leads to Fragile X Tremor Ataxia Syndrome is modifiable by genetic or pharmacologic means, according to new research from U-M Medical School scientists.
In 2009, the Hypertension and Preeclampsia Intervention Trial At near Term-I (HYPITAT- I) trial showed that inducing labor in women with gestational hypertension or preeclampsia at the end of pregnancy reduces the number of high risk situations for the mother, without compromising the health of newborns.
QLT Inc. ("QLT" or the "Company") is pleased to announce the establishment of its commercial presence in the United States through a newly formed U.S. subsidiary, QLT Ophthalmics, Inc. ("QOI"). QOI will take on the sales and marketing of Visudyne(R) in the U.S.
Safe levels of electrical stimulation can enhance your capacity to think more creatively, according to a new study by Georgetown researchers.
The U.S. Food and Drug Administration today approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated with resistance to the individual components of Dovato.
› Verified 4 days ago
| Entity Name | Ascension Providence Rochester Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275656357 PECOS PAC ID: 8820994098 Enrollment ID: O20071117000078 |
News Archive
Expression of a toxic RNA that leads to Fragile X Tremor Ataxia Syndrome is modifiable by genetic or pharmacologic means, according to new research from U-M Medical School scientists.
In 2009, the Hypertension and Preeclampsia Intervention Trial At near Term-I (HYPITAT- I) trial showed that inducing labor in women with gestational hypertension or preeclampsia at the end of pregnancy reduces the number of high risk situations for the mother, without compromising the health of newborns.
QLT Inc. ("QLT" or the "Company") is pleased to announce the establishment of its commercial presence in the United States through a newly formed U.S. subsidiary, QLT Ophthalmics, Inc. ("QOI"). QOI will take on the sales and marketing of Visudyne(R) in the U.S.
Safe levels of electrical stimulation can enhance your capacity to think more creatively, according to a new study by Georgetown researchers.
The U.S. Food and Drug Administration today approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated with resistance to the individual components of Dovato.
› Verified 4 days ago
| Entity Name | Washington Sleep Center Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992063804 PECOS PAC ID: 0143486134 Enrollment ID: O20120718000909 |
News Archive
Expression of a toxic RNA that leads to Fragile X Tremor Ataxia Syndrome is modifiable by genetic or pharmacologic means, according to new research from U-M Medical School scientists.
In 2009, the Hypertension and Preeclampsia Intervention Trial At near Term-I (HYPITAT- I) trial showed that inducing labor in women with gestational hypertension or preeclampsia at the end of pregnancy reduces the number of high risk situations for the mother, without compromising the health of newborns.
QLT Inc. ("QLT" or the "Company") is pleased to announce the establishment of its commercial presence in the United States through a newly formed U.S. subsidiary, QLT Ophthalmics, Inc. ("QOI"). QOI will take on the sales and marketing of Visudyne(R) in the U.S.
Safe levels of electrical stimulation can enhance your capacity to think more creatively, according to a new study by Georgetown researchers.
The U.S. Food and Drug Administration today approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated with resistance to the individual components of Dovato.
› Verified 4 days ago
| Entity Name | Alpha Urgent Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326630716 PECOS PAC ID: 4486060845 Enrollment ID: O20210309002678 |
News Archive
Expression of a toxic RNA that leads to Fragile X Tremor Ataxia Syndrome is modifiable by genetic or pharmacologic means, according to new research from U-M Medical School scientists.
In 2009, the Hypertension and Preeclampsia Intervention Trial At near Term-I (HYPITAT- I) trial showed that inducing labor in women with gestational hypertension or preeclampsia at the end of pregnancy reduces the number of high risk situations for the mother, without compromising the health of newborns.
QLT Inc. ("QLT" or the "Company") is pleased to announce the establishment of its commercial presence in the United States through a newly formed U.S. subsidiary, QLT Ophthalmics, Inc. ("QOI"). QOI will take on the sales and marketing of Visudyne(R) in the U.S.
Safe levels of electrical stimulation can enhance your capacity to think more creatively, according to a new study by Georgetown researchers.
The U.S. Food and Drug Administration today approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated with resistance to the individual components of Dovato.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Muhammad Kashlan, MD 75 Barclay Cir Ste 205, Rochester Hills, MI 48307-5821 Ph: (248) 651-6430 | Dr Muhammad Kashlan, MD 75 Barclay Cir Ste 205, Rochester Hills, MI 48307-5821 Ph: (248) 651-6430 |
News Archive
Expression of a toxic RNA that leads to Fragile X Tremor Ataxia Syndrome is modifiable by genetic or pharmacologic means, according to new research from U-M Medical School scientists.
In 2009, the Hypertension and Preeclampsia Intervention Trial At near Term-I (HYPITAT- I) trial showed that inducing labor in women with gestational hypertension or preeclampsia at the end of pregnancy reduces the number of high risk situations for the mother, without compromising the health of newborns.
QLT Inc. ("QLT" or the "Company") is pleased to announce the establishment of its commercial presence in the United States through a newly formed U.S. subsidiary, QLT Ophthalmics, Inc. ("QOI"). QOI will take on the sales and marketing of Visudyne(R) in the U.S.
Safe levels of electrical stimulation can enhance your capacity to think more creatively, according to a new study by Georgetown researchers.
The U.S. Food and Drug Administration today approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated with resistance to the individual components of Dovato.
› Verified 4 days ago
Dr. Mara L Geiger, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1701 South Blvd E, Ste 290, Rochester Hills, MI 48307 Phone: 248-997-7900 Fax: 248-997-7918 | |
Andrew Dean Scrogin, M. D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1854 W Auburn Rd Ste 100a, Rochester Hills, MI 48309 Phone: 248-696-3170 Fax: 248-696-3175 | |
Dr. Cordell L Yoder, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1701 South Blvd East, Ste 250, Rochester Hills, MI 48307 Phone: 248-293-1002 Fax: 248-293-1272 | |
Lauren Pomorski, PA-C Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1460 Walton Blvd Ste 200, Rochester Hills, MI 48309 Phone: 248-650-1800 Fax: 248-650-1856 | |
Brittany Derra, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1701 South Boulevard E, Suite 290, Rochester Hills, MI 48307 Phone: 734-464-0887 Fax: 734-402-0254 | |
Dr. Freeha Khan, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1701 South Blvd E Ste 300, Rochester Hills, MI 48307 Phone: 248-844-9710 | |
Dr. Todd M Hachigian, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1701 South Blvd E, Ste 290, Rochester Hills, MI 48307 Phone: 248-997-7900 Fax: 248-997-7918 |